Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

FCPA Blog Daily News

Entries in healthcare (5)


China healthcare compliance is still a ‘donations’ minefield

It has been over five years since the start of the GlaxoSmithKline case that rocked the China healthcare industry. At the time, compliance, audit and legal teams were shocked by the prevalence of integrity and corruption issues that had apparently gone unidentified, despite the widespread practice of generating slush funds through fraudulent travel expense claims.

Click to read more ...


Gary Giampetruzzi: Is Small Pharma next for DOJ enforcement? 

For decades, U.S. prosecutors have touted their big victories over big pharma for violations of U.S. laws prohibiting bribery in the U.S. (the federal Anti-Kickback Statute) and abroad (the FCPA). 

Click to read more ...


Practice alert: China adopts new rules on healthcare donations

Last week, China’s chief healthcare regulator, the National Health and Family Planning Commission (NHFPC), published a significant revision to its earlier rules on donations to healthcare entities. This category of entities includes the nation’s network of state-run hospitals and clinics where about 90 percent of citizens get their healthcare. 

Click to read more ...


Mike Scher on VW's compliance screw up (with video)

Michael Horn, president and CEO of Volkswagen Group of America, said Tuesday: "Our company was dishonest... we have totally screwed up."

Click to read more ...


China healthcare crackdown now includes blacklist 

China has issued two new documents in the last two weeks that evidence a continuing emphasis on cracking down on bribery and corruption in the healthcare sector from both the supply and demand sides.

Click to read more ...